Innovations in Hyperpigmentation

被引：0
作者：
Obeng-Nyarko, Charissa N. [1 ,2 ]
Durango, Kevin S. Puerta [1 ,3 ]
Jackson, Shanelle [1 ,4 ]
Taylor, Susan C. [1 ]
机构：
[1] Univ Penn, Dept Dermatol, 3400 Civ Ctr Bouevard, Philadelphia, PA 19104 USA
[2] Florida State Univ, Coll Med, 1115 West Call St, Tallahassee, FL 32304 USA
[3] Geisel Sch Med Dartmouth, 1 Rope Ferry Rd, Hanover, NH 03755 USA
[4] Michigan State Univ, Coll Human Med, 15 Michigan St NE, Grand Rapids, MI 49503 USA
来源：
DERMATOLOGIC CLINICS | 2025年 / 43卷 / 01期
关键词：
Dyschromias; Hyperpigmentation; Innovations; Skin of color; LICHEN-PLANUS PIGMENTOSUS; POST-INFLAMMATORY HYPERPIGMENTATION; TRANEXAMIC ACID; POSTINFLAMMATORY HYPERPIGMENTATION; FRACTIONATED LASER; TOPICAL PRODUCT; VISIBLE LIGHT; GLYCOLIC ACID; DOUBLE-BLIND; EFFICACY;
D O I：
10.1016/j.det.2024.08.009
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The management of dyschromias has been limited until the recent emergence of innovative oral, topical, and procedural solutions. With ongoing research, the future of therapeutics for pigmentary disorders is promising. Future directions will include nanotechnology for cosmeceuticals to improve skin penetration as well as advances in laser technology.
引用
收藏
页码：111 / 121
页数：11
相关论文
共 99 条
  • [1] Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study
    AboAlsoud, Eman Said
    Eldahshan, Ramadan Mohamed
    Mohammed, Hassan AbouKhodair
    Elsaie, Mohamed L.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (06) : 2508 - 2515
  • [2] The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates
    Akinboro, Adeolu Oladayo
    Ezejiofor, Ogochukwu Ifeanyi
    Olanrewaju, Fatai Olatunde
    Oripelaye, Mufutau Muphy
    Olabode, Olatunde Peter
    Ayodele, Olugbenga Edward
    Onayemi, Emmanuel Olaniyi
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 : 245 - 252
  • [3] Alajmi Ali, 2024, JAAD Case Rep, V43, P62, DOI 10.1016/j.jdcr.2023.10.022
  • [4] Almukhtar R, 2021, J DRUGS DERMATOL, V20, P1174, DOI [10.36849/jdd.6182, 10.36849/JDD.6182]
  • [5] Alsulami M, 2023, Case Rep Dermatol Med, V2023
  • [6] Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma
    Arrowitz, Craig
    Schoelermann, Andrea M.
    Mann, Tobias
    Jiang, Lily, I
    Weber, Teresa
    Kolbe, Ludger
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (08) : 1691 - +
  • [7] Treatment of Post-Inflammatory Hyperpigmentation in Patients With Darker Skin Types Using a Low Energy 1,927 nm Non-Ablative Fractional Laser: A Retrospective Photographic Review Analysis
    Bae, Yoon-Soo Cindy
    Rettig, Samantha
    Weiss, Elliot
    Bernstein, Leonard
    Geronemus, Roy
    [J]. LASERS IN SURGERY AND MEDICINE, 2020, 52 (01) : 7 - 12
  • [8] Belzer Annika, 2023, JAAD Case Rep, V34, P45, DOI 10.1016/j.jdcr.2023.01.029
  • [9] A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma
    Bhattacharjee, Rajsmita
    Hanumanthu, Vinod
    Thakur, Vishal
    Bishnoi, Anuradha
    Vinay, Keshavamurthy
    Kumar, Ashok
    Parsad, Davinder
    Kumaran, Muthu Sendhil
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (06) : 1831 - 1836
  • [10] Comparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness
    Callender, Valerie D.
    Orlinsky, Diane
    Simmons-O'Brien, Eva
    Nwade, Nina C.
    Rhodes, Tanya
    Byrd, Angel S.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (01) : 1260 - 1265
12345678910